$1.91
-0.01-0.52%
Last update: Sep 9, 9:40 AM
enGene Therapeutics Inc
ENGNNASDAQ
Earnings: Q3 2026 Earnings were released on Tue Sep 8th, before the market open
enGene Therapeutics Earnings & Forecasts
enGene Therapeutics (ENGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
enGene Therapeutics Guidance
Recent Earnings Results
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | FY '23 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.44 | $-0.47 | $-0.56 | $-0.57 | — |
| Actual | $-0.47 | $-0.43 | $-0.44 | $-0.73 | $-151.22 |
| Surprise | -6.82% | +8.51% | +21.4% | -28.1% | — |
| Revenue | |||||
| Estimate | — | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.43 | $-0.49 | $-0.43 |
| Revenue | |||
| Consensus | — | — | — |
